FDA "consistent" policy on cholesterol reduction claims for supplements urged by CRN.
This article was originally published in The Tan Sheet
Executive Summary
FDA "CONSISTENT" POLICY ON CHOLESTEROL REDUCTION CLAIMS FOR SUPPLEMENTS URGED by the Council for Responsible Nutrition April 8. CRN said "two different sides of FDA are sending conflicting messages regarding appropriate cholesterol claims for dietary supplements" and called on FDA lead deputy commissioner Michael Friedman, MD, to "ensure that the overall agency policy is consistent with the provisions of" the Dietary Supplement Health & Education Act.